If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
125.00    2.00 (1.63%)
Bid:
124.50
Ask:
127.00
Spread: 2.50 (2.008%)
Market Cap: £199.15m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Directorate Change

22 Nov 2023 07:00

RNS Number : 2053U
Redcentric PLC
22 November 2023
 

Redcentric plc

 

Board Appointment

 

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider is pleased to announce the appointment of Oliver Scott as a Non-Executive Director, effective 1 December 2023.

 

Oliver is a partner of Kestrel Partners LLP ("Kestrel"), the independent investment manager, which he co-founded in 2009. Prior to this, Oliver spent 20 years advising smaller quoted and unquoted companies, latterly as a director of KBC Peel Hunt Corporate Finance. He is currently a non-executive director of Smoove PLC and K3 Business Technology PLC, and was previously a non-executive director of Idox PLC, IQGeo Group PLC and KBC Advanced Technology PLC.

 

Kestrel invests in small and microcap UK listed companies with a particular focus on the enterprise software and services sector, and is Redcentric's largest shareholder, with a current holding of 31,355,551 ordinary shares in the Company.

 

Relationship Agreement

 

In conjunction with Oliver's appointment, the Company have entered into a relationship with Kestrel. The key terms of this agreement are as follows:

 

· Kestrel has the right to nominate one person for appointment as a director of the Company providing that Kestrel (together with its individual partners and their affiliates), indirectly or directly, holds no less than 20 per cent, of the voting rights of the Company;

· all transactions, agreements or arrangements entered into between a member of the group and Kestrel and/or any of its associates will be conducted at arm's length and on arm's length commercial terms; 

· Kestrel shall exercise its voting rights to ensure, so far as it is able to do so by the exercise of such rights, that directors independent of Kestrel shall at all times constitute a majority of the Redcentric board;

· Kestrel and its associates will not propose any resolution or other action to cancel the trading of the Company's shares from trading on AIM without the Board's approval; and

· Kestrel and its associates will not solicit proxies unless consistent with the recommendation of the board, exercise powers to requisition a shareholders' meeting, or undertake any action to obtain or consolidate control of the Company or seek to do so, otherwise than in accordance with the Takeover Code.

 

Nick Bate, Chair of Redcentric, commented:

 

"Oliver has been one of the Company's longest standing and largest investors through his role at Kestrel. He brings significant public markets and technology investment knowledge and we look forward to working with him."

 

In accordance with Schedule Two, paragraph (g) of the AIM Rules for Companies ("AIM Rules"), Oliver Rupert Andrew Scott, aged 55, holds or has held in the past 5 years the following directorships and partnerships:

 

 

Current Directorships

Past 5 Years Directorships

Kestrel Partners LLP

6PM Holdings PLC

K3 Business Technology PLC

ClearSpeed Technology Limited

Smoove PLC

Idox PLC

Suffolk Energy Action Solutions SPV Limited

Idox Trustees Limited

Suffolk Energy Action Solutions Limited

IQGeo Group plc

Kestrel Investment Partners LLP

Kestrel Technology Holdings Ltd

ZF Acquisitions Limited

 

There is no further information to be disclosed in relation to the appointment pursuant to Rule 17 and Schedule Two, paragraph (g) of the AIM Rules.

 

 

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

+44 (0)800 983 2522

Cavendish Capital Markets Limited - Nomad and Sole Broker

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0)20 7220 0500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKDBQKBDBPDB
Date   Source Headline
17th Jun 20257:00 amRNSHolding(s) in Company
28th May 20253:59 pmRNSHolding(s) in Company
27th May 202512:00 pmRNSExercise of Options
27th May 20257:00 amRNSDirectorate Change
14th May 20257:00 amRNSExercise of Options
7th May 20257:00 amRNSTrading Update & CEO Appointment
25th Apr 20257:00 amRNSExercise of Options
3rd Apr 20257:00 amRNSExecutive Director Change
2nd Apr 20257:00 amRNSExercise of Options
21st Mar 20253:00 pmRNSExercise of Options
19th Feb 202512:15 pmRNSHolding(s) in Company
17th Feb 20257:00 amRNSExercise of Options
12th Feb 202511:00 amRNSExercise of Options
6th Feb 20257:00 amRNSHolding(s) in Company
5th Feb 202510:00 amRNSExercise of Options
30th Jan 20257:00 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSExercise of Options
27th Jan 20257:00 amRNSBoard Change
20th Jan 20257:00 amRNSDirectorate Change - Group CEO Appointment
6th Jan 20254:00 pmRNSExercise of Options
13th Dec 20245:00 pmRNSExercise of Options
28th Nov 20247:00 amRNSExercise of Options
20th Nov 20247:00 amRNSHalf Year Results
4th Nov 202411:45 amRNSHolding(s) in Company
4th Nov 202411:30 amRNSHolding(s) in Company
1st Nov 20247:00 amRNSBoard Changes
25th Oct 20247:00 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSExercise of Options
9th Oct 202410:15 amRNSExercise of Options
8th Oct 20247:00 amRNSSave As You Earn Share Option Scheme
4th Oct 20243:00 pmRNSExercise of Options
2nd Oct 20245:30 pmRNSExercise of Options
2nd Oct 20247:00 amRNSGrant of Options and PDMR Shareholding
1st Oct 20247:00 amRNSExercise of Options
27th Sep 20242:07 pmRNSResult of AGM
2nd Sep 20242:41 pmRNSPublication of Annual Report and Notice of AGM
23rd Aug 20242:36 pmRNSDirector/PDMR Shareholding
22nd Aug 20247:00 amRNSExercise of Options
15th Aug 20247:00 amRNSPreliminary results announcement FY24
8th Aug 20247:00 amRNSNotice of Results
7th Jun 202410:21 amRNSForm 8.5 (EPT/NON-RI)
6th Jun 20244:56 pmPRNStatement regarding Redcentric plc ("Redcentric")
6th Jun 202412:00 pmPRNForm 8.3 - Redcentric Plc
6th Jun 202410:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jun 20242:29 pmRNSForm 8.3 - Redcentric plc
5th Jun 20249:57 amPRNForm 8.3 - Redcentric Plc
5th Jun 20247:00 amRNSForm 8.3 - Redcentric PLC
4th Jun 202412:02 pmPRNForm 8.3 - Redcentric Plc
3rd Jun 20245:56 pmRNSForm 8.3 - Redcentric PLC
3rd Jun 20241:34 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.